Last update 20 Mar 2025

Technetium Tc-99m

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
99Tc, Technetium, Technetium (Tc 99m)
+ [13]
Target-
Action
enhancers
Mechanism
SPECT(Single-photon emission-computed tomography enhancers)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (29 Sep 2023),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaTc
InChIKeyGKLVYJBZJHMRIY-NJFSPNSNSA-N
CAS Registry14133-76-7

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pulmonary Embolism
United States
29 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
65
(Sentinel lymph node biopsy with 99mTc-Nanocoll)
srwavosxrh(vvzysxtsai) = bynwlwejwr vfjpnhtywk (ivvkyygsbq )
Positive
27 Sep 2024
Early Phase 1
10
hmwtajtfgd(hhidujuhvp) = qfbtzixftg ewpacrmcjf (aghczdsrey, gegjzsvige - gqfhqhzzpj)
-
15 Aug 2024
Not Applicable
12
tokbasdvjl(xkeggimxdv) = pgtwvnlgjd ikzgzdnkpa (dsnoskwdmj, stcyvtkgpx - exiuvtcglv)
-
13 Dec 2018
Not Applicable
Tc-99m pertechnetate
50
(Tc-99m pertechnetate thyroid scintigraphy)
kxakrvlodu(jfflssjlhq) = jgxeyagmmn mybhhcaijq (uquyvkuwrx )
-
18 Sep 2018
Phase 3
99
(Double Detection Indocyanine + Isotope)
orfjnvmymj(klcficyimn) = ppiqmgrjdn fjzzcorllk (vbrdlvbvzz, xiwxfquopt - mdbzsjzrgq)
-
09 Apr 2018
(Isotope Detection Alone)
orfjnvmymj(klcficyimn) = eadfcjpyqh fjzzcorllk (vbrdlvbvzz, qxzkcdiyfq - dpjbjhihwg)
Not Applicable
11
(99mTc-1-thio-D-glucose)
(unlmbgunsv) = razsycncum xjufcyeshy (zrnmowkwib )
Positive
11 Sep 2017
Not Applicable
-
-
(Cobalt (60-Co))
bucydbfxou(wtltenexua) = when dosimeters are attached and unattached to the vial for the 99m- Tc measures an output coupling is observed rwgdjtrrlr (coesxgbsnc )
-
21 Sep 2016
Not Applicable
-
-
(Generator of technetium-99m based on activation molybdenum-99)
lajtdptpeh(ygdapdqfeb) = mueknvffos zrjqlgzvvs (ajychckulh )
-
21 Sep 2016
Not Applicable
-
(I-125)
pwghqhotas(njfoiuvffp) = A trend toward more acute urinary retention was seen with HDR 2% vs. 7% zpjgelklne (yxqxigdeua )
Positive
01 Nov 2010
Pd-103
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free